Boston to curb insurance coverage of GLP-1 drugs for city workers
The PEC voted unanimously on Tuesday to let the city change its Blue Cross Blue Shield of Massachusetts…
Semaglutide Falls Short in Alzheimer’s Phase 3 Trials
Phase 3 trials show oral semaglutide failed to slow early Alzheimer’s progression, potentially limiting its expansion beyond metabolic…
India’s coming Ozempic moment could reshape both waistlines and perceptions
On a recent episode of CBS Sports Golazo, Clint Dempsey couldn’t resist a dig. Sitting alongside Thierry Henry,…
Don't advertise weight-loss drugs: Govt to pharma firms | 'Obesity 'awareness campaigns' also misleading' | Inshorts – Inshorts
Don’t advertise weight-loss drugs: Govt to pharma firms | ‘Obesity ‘awareness campaigns’ also misleading’ | Inshorts InshortsCos told not…
Trump’s economic moves seem contradictory and dangerous but there is a game plan – The Irish Times
This year is looking full of economic danger for US president Donald Trump. Despite what he says, his…
What Big Pharma Won’t Tell You: The Ancient Natural Remedy People Swear By — and It Costs Almost Nothing
Claims that “Big Pharma doesn’t want you to know” about a powerful, nearly free natural remedy circulate widely…
NHS must keep medicine rebate down or lose investment
Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
Agentic AI in healthcare: How Life Sciences marketing could achieve $450B in value by 2028
Agentic AI in healthcare is graduating from answering prompts to autonomously executing complex marketing tasks – and life…
FDA rejects Vanda’s jet lag drug following yearslong dispute and 'long-shot' review – Endpoints News
FDA rejects Vanda’s jet lag drug following yearslong dispute and ‘long-shot’ review Endpoints NewsVanda Pharmaceuticals (VNDA) Faces FDA Setback…
Eli Lilly-backed Insilico eyes beyond pharma with new AI models
Interview Biotech company shares jumped 46% in $300m Hong Kong debut Biotech firm Insilico Medicine leverages artificial intelligence…
China’s new commercial insurance model could broaden access to Alzheimer’s drugs
China’s new commercial insurance formulary looks to expand patient access to Alzheimer’s disease medicines from Eli Lilly and…
10 Healthcare Industry Predictions For 2026
The year 2026 will be a year of tumult in American healthcare. Getty Images As December kicks off,…